The development of a highly selective 5‐HT₁ receptor agonist, sumatriptan, for the treatment of migraine

This publication has 34 references indexed in Scilit:

• Dihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglion
  Neuropharmacology, 1991
• Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan
  The Lancet, 1991
• Preclinical Studies on the Anti-Migraine Drug, Sumatriptan
  European Neurology, 1991
• Lack of Antinociceptive Activity of Sumatriptan in Rodents
  Cephalalgia, 1990
• The concept of selectivity in 5-HT receptor research
  European Journal of Pharmacology: Molecular Pharmacology, 1990
• In vivo effects of sumatriptan (GR 43175) on extracellular levels of 5-HT in the guinea pig
  Neuropharmacology, 1990
• Focal headache during balloon inflation in the internal carotid and middle cerebral arteries.
  Stroke, 1990
• The neurobiology of vascular head pain
  Annals of Neurology, 1984
• A pre-junctional action of 5-hydroxytryptamine and methysergide on noradrenergic nerves in dog isolated saphenous vein
  Journal of Pharmacy and Pharmacology, 1981
• Selective vasoconstriction in carotid vascular bed by methysergide: Possible relevance to its antimigraine effect
  European Journal of Pharmacology, 1974